Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bluestone

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|October 1, 1991
Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathwayC Ferran, M Dy, K Sheehan, et al.
Cellular Immunology|December 1, 1993
T-cell receptor gamma delta diversity and specificity of intestinal intraepithelial lymphocytes: analysis of IEL-derived hybridomasB C Sydora, P F Mixter, B Houlden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987
T cell antigen receptor phosphorylation induced by an anti-receptor antibodyL E Samelson, J J O'Shea, H Luong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient miceC A Reardon, L Blachowicz, T White, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Role of Ti/CD3, Thy-1, and Ly-6 in cytolytic T-cell activation analyzed with Ti loss variantsC Langlet, A Guimezanes, P Kaldy, et al.
Cancer Research|October 27, 1997
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stagesY F Yang, J P Zou, J Mu, et al.
Clinical and Experimental Immunology|May 25, 2010
The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouseL Shoda, H Kreuwel, K Gadkar, et al.
Clinical and Experimental Immunology|December 1, 1991
Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine releaseC Ferran, M Dy, K Sheehan, et al.
Transplantation|October 1, 1990
Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroidsC Ferran, M Dy, S Merite, et al.
European Journal of Immunology|March 1, 1990
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activationC Ferran, K Sheehan, M Dy, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|October 1, 1991
Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathwayC Ferran, M Dy, K Sheehan, et al.
Cellular Immunology|December 1, 1993
T-cell receptor gamma delta diversity and specificity of intestinal intraepithelial lymphocytes: analysis of IEL-derived hybridomasB C Sydora, P F Mixter, B Houlden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987
T cell antigen receptor phosphorylation induced by an anti-receptor antibodyL E Samelson, J J O'Shea, H Luong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient miceC A Reardon, L Blachowicz, T White, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Role of Ti/CD3, Thy-1, and Ly-6 in cytolytic T-cell activation analyzed with Ti loss variantsC Langlet, A Guimezanes, P Kaldy, et al.
Cancer Research|October 27, 1997
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stagesY F Yang, J P Zou, J Mu, et al.
Clinical and Experimental Immunology|May 25, 2010
The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouseL Shoda, H Kreuwel, K Gadkar, et al.
Clinical and Experimental Immunology|December 1, 1991
Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine releaseC Ferran, M Dy, K Sheehan, et al.
Transplantation|October 1, 1990
Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroidsC Ferran, M Dy, S Merite, et al.
European Journal of Immunology|March 1, 1990
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activationC Ferran, K Sheehan, M Dy, et al.
Pageof 3